Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    12205648 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
Condition: Alzheimer Disease
Intervention: Drug: Simvastatin

Indicates status has not been verified in more than two years